Exploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Locally Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT04888403 · UNKNOWN
Trial details
- NCT number
- NCT04888403
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-31
- Primary completion
- 2022-07-20
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.